Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial.
Stone GW, McCullough PA, Tumlin JA, Lepor NE, Madyoon H, Murray P, Wang A, Chu AA, Schaer GL, Stevens M, Wilensky RL, O'Neill WW; CONTRAST Investigators.
Stone GW, et al. Among authors: lepor ne.
JAMA. 2003 Nov 5;290(17):2284-91. doi: 10.1001/jama.290.17.2284.
JAMA. 2003.
PMID: 14600187
Clinical Trial.